Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

Quantitative analysis of [18F]FMISO PET for tumor hypoxia: Correlation with results using immunohistochemistry

Kuangyu Shi, Constantin Maftei, Christine Bayer, Sabrina Astner, Florian Gaertner, Peter Vaupel, Markus Schwaiger, Sung-Cheng Huang and Sibylle Ziegler
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 216;
Kuangyu Shi
1Nuclear Medicine, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constantin Maftei
2Radiation Oncology, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Bayer
2Radiation Oncology, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina Astner
2Radiation Oncology, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian Gaertner
1Nuclear Medicine, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Vaupel
2Radiation Oncology, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schwaiger
1Nuclear Medicine, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sung-Cheng Huang
3Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sibylle Ziegler
1Nuclear Medicine, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

216

Objectives Quantitative evaluation of tumor hypoxia based on [18F]FMISO PET is important for treatment planning in radiotherapy. However the capability of different analysis methods in revealing the underlying hypoxia status, is not clear. This study aims to assess these quantitative analysis methods with the support of histological data.

Methods 16 nude mice with xenografted human squamous cell carcinomas (FaDu or CAL-33) were scanned using 2h FMISO PET and 2 blood samples taken at the end. Tumors were sliced and stained with the hypoxia marker pimonidazole. The hypoxic area was segmented using a k-means clustering algorithm and the hypoxic fraction was calculated as the ratio of the hypoxic area in vital tissue area pooled over 3 tissue slices (top, middle, bottom). PET images were reconstructed using filtered-back projection and tumor and normal organs were outlined manually based on fused CT and PET images. PET images were analyzed using various methods including static analysis (SUV, tumor-to-blood ratio, SUVR) and kinetic modeling (Casciari αkA, irreversible and reversible two-tissue compartment k3, Thorwarth wA, Patlak K, Logan DV, Cho slope) and correlated with the hypoxic fraction.

Results Significant correlations were observed for k3 of the irreversible two compartment model (r=0.68, p=0.004), and tumor-to-brain ratio (r=0.59, p=0.02). The correlation to tumor-to-muscle ratio varies for 6 different muscles assessed here (r=0.59 to -0.28).

Conclusions With the support of histological data, this study shows that different analysis methods for FMISO PET perform differently for the assessment of tumor hypoxia. The irreversible two compartment model has the best performance among the investigated methods. FMISO PET for radiotherapy treatment planning needs to be carefully analyzed and further clinical assessment is needed

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quantitative analysis of [18F]FMISO PET for tumor hypoxia: Correlation with results using immunohistochemistry
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Quantitative analysis of [18F]FMISO PET for tumor hypoxia: Correlation with results using immunohistochemistry
Kuangyu Shi, Constantin Maftei, Christine Bayer, Sabrina Astner, Florian Gaertner, Peter Vaupel, Markus Schwaiger, Sung-Cheng Huang, Sibylle Ziegler
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 216;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Quantitative analysis of [18F]FMISO PET for tumor hypoxia: Correlation with results using immunohistochemistry
Kuangyu Shi, Constantin Maftei, Christine Bayer, Sabrina Astner, Florian Gaertner, Peter Vaupel, Markus Schwaiger, Sung-Cheng Huang, Sibylle Ziegler
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 216;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Clinical Significance of Circulating Anti-Thyroglobulin Autoantibodies After First Remnant Ablation in Patients with Differentiated Thyroid Cancer
  • Feasibility demonstration of imaging in vivo biodistribution of Yttrium-90 microspheres after radioembolization with a digital detector PET/CT system.
  • Successful PET Imaging of Pancreatic Tumors in Mice, Achieved by Reverse Contrast CT
Show more Oncology: Basic, Translational & Therapy

Basic Science (Oncology): Tumor Characterization & Microenvironment

  • First clinical observations of HER2 specific [111In]ABY-025 metastatic detection capability in females with metastatic breast cancer
  • Kras mutation causes increased 18F-FDG uptake in experimental models of colorectal cancer
Show more Basic Science (Oncology): Tumor Characterization & Microenvironment

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire